Piper Sandler Lowers Cigna Group (NYSE:CI) Price Target to $346.00

Cigna Group (NYSE:CI) had its price target reduced by investment analysts at Piper Sandler from $370.00 to $346.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. The firm currently has an “overweight” rating on the health services provider’s stock. Piper Sandler’s price target points to a potential upside of 26.47% from the stock’s previous close.

A number of other brokerages also recently issued reports on CI. The Goldman Sachs Group lifted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Guggenheim raised their target price on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. UBS Group boosted their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $338.30.

Cigna Group Stock Up 0.3%

Shares of Cigna Group stock opened at $273.58 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89. The company has a market capitalization of $72.37 billion, a P/E ratio of 11.60, a P/E/G ratio of 0.99 and a beta of 0.28. The company has a 50 day moving average of $278.51 and a 200 day moving average of $277.06.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Institutional Trading of Cigna Group

A number of large investors have recently bought and sold shares of CI. Caerus Investment Advisors LLC acquired a new stake in shares of Cigna Group during the first quarter worth about $294,000. First Nebraska Trust Co acquired a new position in Cigna Group in the 1st quarter valued at about $204,000. Asset Dedication LLC raised its stake in Cigna Group by 91.3% during the 1st quarter. Asset Dedication LLC now owns 2,129 shares of the health services provider’s stock valued at $568,000 after acquiring an additional 1,016 shares during the last quarter. Maripau Wealth Management LLC lifted its position in Cigna Group by 4.0% during the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock worth $287,000 after acquiring an additional 41 shares during the period. Finally, Allen Capital Group LLC lifted its position in Cigna Group by 6.4% during the 1st quarter. Allen Capital Group LLC now owns 794 shares of the health services provider’s stock worth $212,000 after acquiring an additional 48 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.